The use of valproic acid in HIV-positive patients

Annals of Pharmacotherapy

Volumn 33, Issue 10, 1999, Pages 1113-1116

  Jennings, Heath R ^a   Romanelli, Frank ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b University of Kentucky   (United States)

Author keywords

AIDS; HIV; Valproic acid

Indexed keywords

CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; ZIDOVUDINE;

ANTICONVULSANT THERAPY; ARTICLE; CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG METABOLISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPENIA; NEPHROTOXICITY; PANCREATITIS; PRIORITY JOURNAL; RASH; RISK BENEFIT ANALYSIS; SEIZURE; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; VIRUS LOAD; VIRUS REPLICATION;

ANTICONVULSANTS; HIV INFECTIONS; HUMANS; SEIZURES; VALPROIC ACID;

EID: 0032832771     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.19014     Document Type: Article

References (23)

1. Wong MC, Suite ND, Labar DR. Seizures in human immunodeficiency virus infection. Arch Neurol 1990:47:640-2.
2. Holtzman D, Kaku DA, So YT. New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases. Am J Med 1989;87:173-6.
3. Halman MH, Worth JL, Sanders KW, Renshaw PF, Murray GB. Anti-convulsant use in the treatment of manic syndromes in patients with HIV-1 infection. J Neuropsychiatry Clin Neurosci 1993;5:430-4.
4. Wiley CA. Neuromuscular diseases in AIDS. FASEB J 1989;3:2503-11.
5. Simpson DM, Olney RK. Peripheral neuropathies associated with human immunodeficiency virus infection. Neurol Clin 1992;10:685-711.
6. Rundell JR, Wise MG. Causes of organic mood disorder. J Neuropsychiatry Clin Neurosci 1989; 1:398-400.
7. Toler SM, Wilkerson MA, Porter WH, Smith AJ, Chandler MHH. Severe phenytoin intoxication as a result of altered protein binding in AIDS. Ann Pharmacother 1990;24:698-700.
8. Burger DM, Meenhorst PL, Mulder JW, Kraaijeveld CL, Koks CHW, Bull A, et al. Therapeutic drug monitoring of phenytoin in patients with the acquired immunodeficiency syndrome. Ther Drug Monit 1994;16: 616-20.
9. Rao K. Acute renal failure syndromes in human immunodeficiency virus infection. Semin Nephrol 1998;18:378-95.
10. RachBeisel JA, Weintraub E. Valproic acid treatment of AIDS-related mania. J Clin Psychiatry 1997;58:406-7.
11. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, et al. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA 1998;280:78-86.
12. Barry M, Gibbons S, Back D, Mulcahy F. Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations. Clin Pharmacokinet 1997;32:194-209.
13. Hug B, Kaeser YA, Haefeli WE, Battegay M. Antiretroviral therapy and antiepileptics. Case report discussion. Schweiz Med Wochenschr 1998; 128:1138-44.
14. Akula SK, Rege AB, Dreisbach AW, Dejace P, Lertora J. Valproic acid increases cerebrospinal fluid zidovudine levels in a patient with AIDS. Am J Med Sci 1997;313:244-6.
15. Taubret A-M, Singlas E. Drug interactions with antiviral drugs. Clin Pharmacokinet 1996;30:385-401.
16. Simon G, Moog C, Obert G. Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus. Chem Biol Interact 1994;91:111-21.
17. Simon G, Moog C, Oben G. Effects of glutathione precursors on human immunodeficiency virus replication. Chem Biol Interact 1994;91:217-24.
18. Witvrouw M, Schmit J, Remoortel BV, Daelemans D, Este JA, Vandamme AM, et al. Cell type-dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitro. AIDS Res Hum Retroviruses 1997;13:187-92.
19. Kameoka M, Okada Y, Tobiume M, Kimura T, Ikuta K. Intracellular glutathione as a possible direct blocker of HIV type 1 reverse transcription. AIDS Res Hum Retroviruses 1996;12:1635-8.
20. Moog C, Kuntz-Simon G, Caussin-Schwemling C, Obert G. Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels. J Gen Virol 1996;77:1993-9.
21. Kuntz-Simon G, Obert G. Sodium valproate, an anticonvulsant drug, stimulates human cytomegalovirus replication. J Gen Virol 1995;76: 1409-15.
22. Dasgupta A, McLemore JL. Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus. Ther Drug Monit 1998;20:63-7.
23. Jefferson JW. Possible risks associated with valproate treatment of AIDS-related mania (letter). J Clin Psychiatry 1998;59:317.